XML 53 R44.htm IDEA: XBRL DOCUMENT v3.23.1
Intangible Assets (Details Narrative) - In Process Research and Development [Member] - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Mar. 31, 2023
Dec. 31, 2022
Dec. 31, 2022
EGEN Inc [Member] | IPR and D Drug Technology Platforms [Member]      
Finite-Lived Intangible Assets [Line Items]      
Estimated acquisition price $ 24.2    
IPR and D Drug Technology Platforms [Member]      
Finite-Lived Intangible Assets [Line Items]      
Asset impairment charges     $ 13.4
Non-cash charge   $ 13.4